Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
13,424,543
-
Number of holders
-
46
-
Total 13F shares, excl. options
-
1,387,298
-
Shares change
-
+911,648
-
Total reported value, excl. options
-
$49,914,163
-
Value change
-
+$34,081,287
-
Number of buys
-
36
-
Number of sells
-
-11
-
Price
-
$35.98
Significant Holders of Tonix Pharmaceuticals Holding Corp. - Common Stock, par value $0.001 per share (TNXP) as of Q2 2025
51 filings reported holding TNXP - Tonix Pharmaceuticals Holding Corp. - Common Stock, par value $0.001 per share as of Q2 2025.
Tonix Pharmaceuticals Holding Corp. - Common Stock, par value $0.001 per share (TNXP) has 46 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,387,298 shares
of 13,424,543 outstanding shares and own 10.33% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (420,448 shares), GEODE CAPITAL MANAGEMENT, LLC (175,212 shares), VANGUARD GROUP INC (164,732 shares), NORTHERN TRUST CORP (164,022 shares), STATE STREET CORP (123,257 shares), Nuveen, LLC (51,892 shares), Susquehanna Portfolio Strategies, LLC (41,454 shares), UBS Group AG (22,463 shares), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (21,732 shares), and MORGAN STANLEY (18,928 shares).
This table shows the top 46 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.